Analysis of tumor specimens of gastric carcinoma patients using immunohistochemistry revealed increased CEACAM6 protein levels were associated with a higher stage, and that high CEACAM6 protein levels were associated with a shorter recurrence free survival [113]. This evidence concerns the gene CEACAM6 and neoplasm.